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Valvulopathies  multiples  sévères  associées  à  la  prise  de  bromocriptine
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A  76-year-old  man  presented  with  severe  dyspnoea,  leading  to  urgent  hospitalization  for
congestive  heart  failure.  The  patient  had  Parkinson’s  disease  treated  with  bromocriptine
at  a  dose  of  30  mg/day  for  more  than  7  years  (total  cumulative  dose  =  30  ×  365  ×  7 =  77  g);
he  did  not  have  cardiovascular  risk  factors.  Transthoracic  Doppler  echocardiography  (TTE)
showed  a  dilated  left  ventricle  with  normal  ejection  fraction  and  no  wall  motion  abnormali-
ties.  Both  left  heart  valves  (mitral  and  aortic)  were  thickened  with  a  drumstick  appearance
and  restrictive  motion  of  the  two  mitral  leaﬂets  causing  severe  mitral  regurgitation.  There
was  also  a  restrictive  motion  of  the  right  and  the  no  coronary  aortic  cusps  leading  to  sig-
niﬁcant  aortic  valve  regurgitation.  The  left  atrium  was  dilated  and  there  was  signiﬁcant
tricuspid  regurgitation  with  thickened  tricuspid  leaﬂets  and  a  dilated  tricuspid  annulus;
the  estimated  pulmonary  artery  systolic  pressure  was  around  65  mmHg.  Coronary  angiogra-
phy  showed  three-vessel  disease.  However,  after  multidisciplinary  staff  consultation  and  in
accordance  with  his  family,  the  patient  did  not  have  cardiac  surgery  because  of  his  severe
Parkinson’s  disease  and  global  mediocre  status.  In  fact,  the  operative  risk  was  felt  to  be
greater  than  the  beneﬁts  of  undergoing  coronary  artery  bypass  graft  and  double  mitral  and
aortic  valve  replacement  associated  with  tricuspid  annuloplasty.
Previous  studies  have  shown  an  association  between  ergot  alkaloids,  such  as  per-
golide  or  cabergoline,  and  the  occurrence  of  toxic  drug-induced  valvular  disease.
However,  the  association  between  severe  valvular  heart  disease  and  bromocriptine  is
extremely  rare  (one  case  from  Marseille  with  a  similar  total  cumulative  dose  of  73  g  was
described  in  2002;  the  patient  had  severe  multiple  valve  regurgitation).  Although  there
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Figure 1. Transthoracic echocardiography (apical four-chamber
view) showing thickened and restrictive motion of both mitral
leaﬂets with a drumstick appearance (arrows). AML: anterior mitral
leaﬂet; LA: left atrium; LV: left ventricle; PML: posterior mitral
leaﬂet; RA: right atrium; RV: right ventricle.
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Supplementary  data  (Videos  1—4)  associated  with  this  arti-igure 2. Apical four-chamber view showing severe mitral valve
egurgitation with a regurgitant oriﬁce of 46 mm2. LA: left atrium;
V: left ventricle.
c
oigure 3. Parasternal long-axis view with color Doppler focused
t the aortic valve showing signiﬁcant aortic regurgitation (arrow).
o: aorta; LA: left atrium; RV: right ventricle.
as  no  histological  proof  however,  given  the  time  course,
umulative  dose,  chemical  similarity  of  bromocriptine  to
ther  ergo  derivatives  and  typical  valve  lesions  seen  on  TTE
Figs.  1—3; Videos  1—4),  we  felt  that  there  was  a  strong
nd  probable  association  between  prolonged  bromocriptine
reatment  and  the  occurrence  of  severe  multiple  valves  dis-
ase.
To  date,  this  patient  is  managed  medically  and
s  still  alive;  bromocriptine  treatment  was  obviously
nterrupted.
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ppendix A. Supplementary datale  can  be  found,  in  the  online  version,  at  http://dx.doi.
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